4552 — JCR Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- ¥64bn
- ¥109bn
- ¥40bn
Japan approves more COVID-19 vaccines, expands state of emergency (updated)
Moderna considering manufacturing COVID-19 vaccines in Japan - media
Japan to approve more COVID-19 vaccines as state of emergency set to widen (updated)
Japan to hold off on using AstraZeneca COVID-19 vaccine - media
Japan health panel approves Moderna, AstraZeneca COVID-19 vaccines (updated)
Table: Jcr Pharmaceuticals -2020/21 group results
Table: Jcr Pharmaceuticals -2020/21 parent results
Japan getting more Pfizer COVID-19 vaccines to immunise elderly faster
Japan to get first batches of AstraZeneca COVID-19 vaccine from U.S. (updated)
Japan to get first batches of AstraZeneca COVID-19 vaccine from U.S.
Japan's vaccine minister says inoculation pace to accelerate in May (updated)
Interview: Japan vaccine czar Kono says inoculation pace to accelerate in May
Table: Jcr Pharmaceuticals -2020/21 group forecast
Brief: JCR Pharmaceuticals Announces Approval Of IZCARGO In Japan
Daiichi Sankyo says it has begun producing AstraZeneca's COVID-19 vaccine in Japan
Daiichi Sankyo says it has begun producing AstraZeneca's COVID-19 vaccine in Japan
Japan's JCR Pharma to build new plant to produce COVID-19 vaccine solution
Brief: JCR Pharmaceuticals - To Start Construction On New COVID-19 Vaccine Plant In July, Scheduled Completion In Oct 2022
AstraZeneca files for Japan approval of COVID-19 vaccine, 2nd after Pfizer treatment (updated)